Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 19 - Number 10

Review Article

Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A Review

, 19(10): 765 - 781

Seema Rohilla*, Harish Dureja and Vinay Chawla

DOI: 10.2174/1568009619666190326120457

Review Article

Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer

, 19(10): 782 - 795

John W. Wright*, Kevin J. Church and Joseph W. Harding

DOI: 10.2174/1568009619666190326130008

Research Article

Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells

, 19(10): 796 - 806

Yufeng Wu, Zhen He, Shaomei Li, Hong Tang, Lili Wang, Sen Yang, Bing Dong, Jianjun Qin, Yue Sun, Han Yu, Yu Zhang, Yi Zhang, Yongjun Guo and Qiming Wang*

DOI: 10.2174/1568009619666190103122735

Research Article

Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells

, 19(10): 807 - 816

Laura Pietrovito, Giuseppina Comito, Matteo Parri, Elisa Giannoni, Paola Chiarugi and Maria Letizia Taddei*

DOI: 10.2174/1568009619666190115142858

Research Article

Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer

, 19(10): 817 - 827

Jianbo Zhu, Lijuan Deng, Baozhen Chen, Wenqing Huang, Xiandong Lin, Gang Chen, Chi-Meng Tzeng*, Mingang Ying* and Zhongxian Lu*

DOI: 10.2174/1568009619666190620112546

Research Article

Inhibition of PI3K/mTOR Pathways with GDC-0980 in Pediatric Leukemia: Impact on Abnormal FLT-3 Activity and Cooperation with Intracellular Signaling Targets

, 19(10): 828 - 837

Abdulhameed Al-Ghabkari*, Maneka A. Perinpanayagam and Aru Narendran

DOI: 10.2174/1568009619666190326120833

Research Article

Polyisoprenylated Cysteinyl Amide Inhibitors Deplete K-Ras and Induce Caspase-dependent Apoptosis in Lung Cancer Cells

, 19(10): 838 - 851

Augustine T. Nkembo, Felix Amissah, Elizabeth Ntantie, Rosemary A. Poku, Olufisayo O. Salako, Offiong Francis Ikpatt and Nazarius S. Lamango*

DOI: 10.2174/1568009619666190325144636


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog